✦ LIBER ✦

6088 Safety and efficacy of bevacizumab (BEV) and chemotherapy in elderly patients with metastatic colorectal cancer (mCRC): results from the BEAT observational cohort study

✍ Scribed by Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolomeo, M.; Mazier, M.A.; Georgoulias, V.; Bridgewater, J.; Cunningham, D.

Book ID: 122342971
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71183-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An observational cohort study of bevaciz

An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group

✍ Tahover, Esther; Hubert, Ayala; Temper, Mark; Salah, Azzam; Peretz, Tamar; Hambu 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 362 KB

Efficacy and safety of bevacizumab in el

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

✍ Slavicek, Lubomir; Pavlik, Tomas; Tomasek, Jiri; Bortlicek, Zbynek; Buchler, Tom 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 209 KB

6113 POSTER Efficacy and Safety at 12 Mo

6113 POSTER Efficacy and Safety at 12 Months of 1st Line Bevacizumab (Bv) Plus Chemotherapy (CT) in Elderly Patients (Pt) With Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice – the CONCERT French Observational Cohort Study

✍ Bennouna, J.; Phelip, J.M.; Andrée, T.; Asselain, B.; Senellart, H.; Morsli, O.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and efficacy of first-line bevaci

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB

Treatment Patterns and Clinical Outcomes

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study

✍ Bendell, J. C.; Bekaii-Saab, T. S.; Cohn, A. L.; Hurwitz, H. I.; Kozloff, M.; Te 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 495 KB

Safety and Effectiveness of Bevacizumab

Safety and Effectiveness of Bevacizumab Treatment for Metastatic Colorectal Cancer: Final Results from the Avastin® Registry – Investigation of Effectiveness and Safety (ARIES) Observational Cohort Study

✍ Hurwitz, H.I.; Bekaii-Saab, T.S.; Bendell, J.C.; Cohn, A.L.; Kozloff, M.; Roach, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 495 KB